The Kenya Medical Research Institute (KEMRI) has announced a new partnership with the Bill & Melinda Gates Foundation aimed at boosting women’s health research and innovation throughout Africa.
This initiative, called the Leadership for Innovation and Excellence in Accelerating Research on Women’s Health (LEA-WH) programme, represents a significant investment of Ksh516 million (USD 4 million) and is set to kick off in January 2026.
Over the next three years, the programme will focus on mentoring and empowering a fresh wave of African scientists and innovators to create homegrown, evidence-based solutions that tackle the pressing health challenges faced by women.
The LEA-WH initiative is all about enhancing leadership in scientific research while also building the capacity for innovation that directly meets Africa’s unique health needs.
During the announcement, Prof. Elijah Songok, KEMRI’s Acting Director General, emphasized the institution’s dedication to fostering African-led scientific excellence.
“The LEA-WH Programme showcases KEMRI’s commitment to cultivating scientific leadership that is inclusive, innovative, and rooted in Africa,” he said.
He also pointed out that the programme aims not only to elevate research excellence but also to bridge the gap between scientific findings and practical solutions for women’s health.
In collaboration with the U.S. National Academy of Medicine (NAM), the programme will be overseen by the LEA-WH Advisory Council, which is chaired by Prof. Songok and directed by Prof. Elizabeth Anne Bukusi, a well-respected expert in reproductive health and research ethics.
Prof. Bukusi shared that the initiative is crafted to encourage collaboration and sustainability within Africa’s research landscape.
“Our vision is to cultivate a dynamic ecosystem where African innovators take the lead in shaping the future of women’s health,” she remarked.
By 2033, the LEA-WH program is set to deliver real results that will foster innovation and sustainability in the health sector. This includes launching 5 to 10 groundbreaking health products for market testing, backing 5 to 10 startups and 5 to 10 patent applications, helping up to 50% of fellows land competitive research and development (R&D) grants, and securing between USD 3 to 5 million in follow-on innovation funding.
